Home › Funds › PFM Health Sciences, LP › MDGL
PFM Health Sciences, LP position in MDGL
MADRIGAL PHARMACEUTICALS INC · Health Care
PFM Health Sciences, LP reported holding 29,313 shares of MDGL (MADRIGAL PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$15.7M, representing 1.38% of its reported portfolio and ranking #24 among its reported holdings. PFM Health Sciences, LP has disclosed MDGL holdings in 5 of the last 10 reported quarters, going back to Q1 2024.
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
How PFM Health Sciences, LP's MDGL position evolved
PFM Health Sciences, LP first disclosed a stake in MDGL in Q1 2024 at 29,973 shares (US$8.0M). The position peaked in Q1 2026 at 34,146 shares, worth US$17.9M. Across 5 filings, PFM Health Sciences, LP increased the stake 1 time(s), trimmed it 1 time(s) and left it unchanged 1 time(s). The most recent filing (Q2 2026) shows 29,313 shares valued at US$15.7M — a reduction of -4,833 shares quarter over quarter.. Notable position changes include a 370% increase in Q1 2026 (shares rose 3% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q1 2024 | 29.97K | $8.00M | New |
| Q2 2024 | 29.97K | $8.40M | Hold |
| Q4 2025 | 7.26K | $4.23M | New |
| Q1 2026 | 34.15K | $17.87M | Add |
| Q2 2026 | 29.31K | $15.74M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About MDGL and 13F data
MDGL (MADRIGAL PHARMACEUTICALS INC) is a Health Care company. 48 other funds we track also report a position in MDGL — the largest reported positions include BAKER BROS. ADVISORS LP (US$1.15B), RTW INVESTMENTS, LP (US$1.07B), Janus Henderson Group (US$1.05B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding MDGL
- BAKER BROS. ADVISORS LP 2.14M sh · $1.15B · Q2 2026
- RTW INVESTMENTS, LP 1.99M sh · $1.07B · Q2 2026
- Janus Henderson Group 2.02M sh · $1.05B · Q1 2026
- Jupiter Topco LLC 1.94M sh · $1.04B · Q2 2026
- Avoro Capital Advisors LLC 1.83M sh · $984.41M · Q2 2026
- Paulson & Co 1.34M sh · $719.52M · Q2 2026
- PAULSON & CO. INC. 1.34M sh · $719.52M · Q2 2026
- ARMISTICE CAPITAL, LLC 288.00K sh · $154.64M · Q2 2026
- Rock Springs Capital Management LP 175.00K sh · $93.97M · Q2 2026
- Erste Asset Management GmbH 110.21K sh · $58.11M · Q2 2026
More on PFM Health Sciences, LP
FAQ
How long has PFM Health Sciences, LP held MDGL?
PFM Health Sciences, LP has disclosed MDGL holdings in 5 of the last 10 reported quarters, going back to Q1 2024.
What is PFM Health Sciences, LP's current position in MDGL?
As of Q2 2026, PFM Health Sciences, LP holds 29.31K shares of MDGL (MADRIGAL PHARMACEUTICALS INC), valued at $15.74M, representing 1.38% of its reported portfolio and ranking #24.
Has PFM Health Sciences, LP been buying or selling MDGL?
In the latest 13F filing (Q2 2026), PFM Health Sciences, LP reduced its position in MDGL. The position peaked in Q1 2026 at 34.15K shares.
Which other funds hold MDGL?
Other major institutional holders of MDGL include BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, Janus Henderson Group, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.